ScholarIQanswers from OpenAlex

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation

PaperCitations, authors & open-access status

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation have?

ScholarIQcitation count

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation has 15 citations in the OpenAlex counts ScholarIQ stores.

When was ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation published?

ScholarIQyear

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation has 2015 year in the ScholarIQ index.

What is the open-access status of ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation?

ScholarIQoa status

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation has diamond oa status in the ScholarIQ index.

What is the DOI of ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation?

ScholarIQdoi

The DOI for ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation is on the source record.

What is the PMID of ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation?

ScholarIQpmid

The PMID for ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation is on the source record.

What is the OpenAlex record for ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation?

ScholarIQopenalex

The OpenAlex for ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial